+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

OraSure Technologies Inc (OSUR) - Product Pipeline Analysis, 2021 Update

FEATURED COMPANIES

  • Maxim Biomedical Inc
  • MedMira Inc
  • Nymox Pharmaceutical Corp
  • Psychemedics Corp
  • Trinity Biotech Plc
  • Zoetis Inc
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

OraSure Technologies Inc (OraSure) develops, manufactures and distributes oral fluid diagnostic and collection devices and other diagnostic products for detection and diagnosis of critical medical conditions. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; Ebola virus, Zika virus and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific. OraSure is headquartered in Bethlehem, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company OraSure Technologies Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Maxim Biomedical Inc
  • MedMira Inc
  • Nymox Pharmaceutical Corp
  • Psychemedics Corp
  • Trinity Biotech Plc
  • Zoetis Inc
  • MORE
OraSure Technologies Inc Company Overview
  • OraSure Technologies Inc Company Snapshot
  • OraSure Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
  • OraSure Technologies Inc - Pipeline Analysis Overview
  • Business Description
  • OraSure Technologies Inc - Key Facts
  • OraSure Technologies Inc - Major Products and Services
  • OraSure Technologies Inc Pipeline Products by Development Stage
OraSure Technologies Inc Pipeline Products Overview
  • In-home Self-Test - Pan-SARS-Coronavirus
  • In-home Self-Test - Pan-SARS-Coronavirus Product Overview
  • Intercept i2 he
  • Intercept i2 he Product Overview
  • Next-Generation Colli-Pee
  • Next-Generation Colli-Pee Product Overview
  • Oral Fluid Antibody ELISA Test - COVID-19
  • Oral Fluid Antibody ELISA Test - COVID-19 Product Overview
  • OraQuick Coronavirus Rapid Antigen Self-Test - OTC
  • OraQuick Coronavirus Rapid Antigen Self-Test - OTC Product Overview
  • OraQuick Coronavirus Rapid Antigen Self-Test - Prescription Use
  • OraQuick Coronavirus Rapid Antigen Self-Test - Prescription Use Product Overview
  • OraQuick Coronavirus Rapid Antigen Self-Test - Professional Use
  • OraQuick Coronavirus Rapid Antigen Self-Test - Professional Use Product Overview
  • OraQuick Rapid Zika Virus Test
  • OraQuick Rapid Zika Virus Test Product Overview
  • OraSure Oral Antibody Collection Device
  • OraSure Oral Antibody Collection Device Product Overview
  • VAX-ID
  • VAX-ID Product Overview
OraSure Technologies Inc - Key Competitors

OraSure Technologies Inc - Key Employees
  • OraSure Technologies Inc - Key Employee Biographies
OraSure Technologies Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • OraSure Technologies Inc, Recent Developments
  • May 12, 2021: OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 18, 2021
  • May 05, 2021: OraSure Technologies Announces First Quarter 2021 Financial Results and Provides COVID-19 Update
  • Mar 01, 2021: OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update
  • Feb 24, 2021: OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors Conference
  • Jan 05, 2021: OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference
  • Oct 21, 2020: OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET
  • Jan 22, 2020: DNA Genotek announces FDA general use clearance for Oragene - Dx family of products
  • Nov 26, 2019: OraSure to Commemorate World AIDS Day by Ringing NASDAQ Opening Bell
  • Nov 06, 2019: OraSure announces 2019 third quarter financial results
  • Oct 11, 2019: FDA clears OraSure’s OraQuick Ebola Test for marketing
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • OraSure Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
  • OraSure Technologies Inc Pipeline Products by Equipment Type
  • OraSure Technologies Inc Pipeline Products by Indication
  • OraSure Technologies Inc, Key Facts
  • OraSure Technologies Inc, Major Products and Services
  • OraSure Technologies Inc Number of Pipeline Products by Development Stage
  • OraSure Technologies Inc Pipeline Products Summary by Development Stage
  • In-home Self-Test - Pan-SARS-Coronavirus - Product Status
  • In-home Self-Test - Pan-SARS-Coronavirus - Product Description
  • Intercept i2 he - Product Status
  • Intercept i2 he - Product Description
  • Next-Generation Colli-Pee - Product Status
  • Next-Generation Colli-Pee - Product Description
  • Oral Fluid Antibody ELISA Test - COVID-19 - Product Status
  • Oral Fluid Antibody ELISA Test - COVID-19 - Product Description
  • OraQuick Coronavirus Rapid Antigen Self-Test - OTC - Product Status
  • OraQuick Coronavirus Rapid Antigen Self-Test - OTC - Product Description
  • OraQuick Coronavirus Rapid Antigen Self-Test - Prescription Use - Product Status
  • OraQuick Coronavirus Rapid Antigen Self-Test - Prescription Use - Product Description
  • OraQuick Coronavirus Rapid Antigen Self-Test - Professional Use - Product Status
  • OraQuick Coronavirus Rapid Antigen Self-Test - Professional Use - Product Description
  • OraQuick Rapid Zika Virus Test - Product Status
  • OraQuick Rapid Zika Virus Test - Product Description
  • OraSure Oral Antibody Collection Device - Product Status
  • OraSure Oral Antibody Collection Device - Product Description
  • VAX-ID - Product Status
  • VAX-ID - Product Description
OraSure Technologies Inc, Key Employees
  • OraSure Technologies Inc, Key Employee Biographies
  • OraSure Technologies Inc, Other Locations
  • OraSure Technologies Inc, Subsidiaries
  • Glossary
List of Figures
  • OraSure Technologies Inc Pipeline Products by Equipment Type
  • OraSure Technologies Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
  • Maxim Biomedical Inc
  • Zoetis Inc
  • Trinity Biotech Plc
  • Nymox Pharmaceutical Corp
  • MedMira Inc
  • Psychemedics Corp
Note: Product cover images may vary from those shown
Adroll
adroll